Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ironwood Pharmaceuticals (IRWD) Current Assets: 2010-2025

Historic Current Assets for Ironwood Pharmaceuticals (IRWD) over the last 15 years, with Sep 2025 value amounting to $273.8 million.

  • Ironwood Pharmaceuticals' Current Assets rose 53.32% to $273.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $273.8 million, marking a year-over-year increase of 53.32%. This contributed to the annual value of $182.4 million for FY2024, which is 21.83% down from last year.
  • According to the latest figures from Q3 2025, Ironwood Pharmaceuticals' Current Assets is $273.8 million, which was up 42.81% from $191.8 million recorded in Q2 2025.
  • Ironwood Pharmaceuticals' Current Assets' 5-year high stood at $866.4 million during Q1 2023, with a 5-year trough of $160.6 million in Q1 2025.
  • Its 3-year average for Current Assets is $276.8 million, with a median of $208.2 million in 2024.
  • In the last 5 years, Ironwood Pharmaceuticals' Current Assets surged by 65.73% in 2021 and then slumped by 75.97% in 2024.
  • Over the past 5 years, Ironwood Pharmaceuticals' Current Assets (Quarterly) stood at $745.2 million in 2021, then increased by 4.75% to $780.6 million in 2022, then plummeted by 70.12% to $233.3 million in 2023, then declined by 21.83% to $182.4 million in 2024, then spiked by 53.32% to $273.8 million in 2025.
  • Its Current Assets stands at $273.8 million for Q3 2025, versus $191.8 million for Q2 2025 and $160.6 million for Q1 2025.